Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults
Response to Wechowski
- Thomas J. Hoerger, PHD1,
- Katherine A. Hicks, MS1,
- Stephen W. Sorensen, PHD2,
- William H. Herman, MD, MPH345,
- Robert E. Ratner, MD6,
- Ronald T. Ackermann, MD, MPH7,
- Ping Zhang, PHD2 and
- Michael M. Engelgau, MD2
- 1Center of Excellence in Health Promotion Economics, RTI International, Research Triangle Park, North Carolina
- 2Centers for Disease Control and Prevention, Atlanta, Georgia
- 3Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan
- 4Department of Epidemiology, University of Michigan Health System, Ann Arbor, Michigan
- 5Michigan Diabetes Research and Training Center, University of Michigan Health System, Ann Arbor, Michigan;the
- 6MedStar Research Institute, Washington, D.C.
- 7Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana
- Corresponding author: Thomas J. Hoerger, PhD, RTI International, 3040 Cornwallis Rd., P.O. Box 12194, Research Triangle Park, NC 27709. E-mail: tjh{at}rti.org
We appreciate Dr. Wechowski's interest (1) in our study (2) and agree that it is important to evaluate the cost-effectiveness of screening for pre-diabetes and of diabetes prevention on a country-by-country basis. Cost-effectiveness …
